亚洲 · 综合新闻 · China Daily
China's innovative therapies lead new cancer battle
Until satri-cel's arrival, commercial CAR T-cell products had been restricted to treating blood cancers. Conquering solid tumors, which make up most human cancers, marks a…
在 China Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (global.chinadaily.com.cn)
